Absations News Today

-- diabetes drug avandia, examining the potential links to heart attacks and the fda is accusing glaxosmithkline of withholding information on risks associated with the drug. fox business networks ashley webster, live in new york with me. whats been the response of the drug makers to the absations? >> its been interesting. this was a drug that was introduced back in 1999 and was tremendously successful, although be it very controversial but sales by 2006 had hit $3 billion. but these concerns ov...